Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Guardant Health, Inc.DEBT 1 250 2 1(GH) | 0 | 0 | 0 | $0 | $227.41M | 7.99% | +$227.41M |
| NovoCure LimitedNOTE 11 0(NVCR) | 0 | 0 | 0 | $134.50M | $136.61M | 4.80% | +$2.11M |
| Neurocrine Biosciences, Inc.(NBIX) | 901,790 | 1,191,925 | +290,135 | $123.09M | $131.83M | 4.63% | +$8.73M |
| Legend Biotech CorporationADS(LEGN) | 2,977,951 | 2,977,951 | 0 | $96.90M | $101.04M | 3.55% | +$4.14M |
| Repligen CorporationNOTE 1 000 12 1(RGEN) | 0 | 0 | 0 | $114.80M | $95.84M | 3.37% | -$18.96M |
| argenx SEADR(ARGX) | 80,766 | 160,849 | +80,083 | $49.67M | $95.20M | 3.35% | +$45.53M |
| Xenon Pharmaceuticals Inc.(XENE) | 2,913,964 | 2,709,875 | -204,089 | $114.23M | $90.92M | 3.20% | -$23.31M |
| iRhythm Holdings, Inc.NOTE 1 500 9 0(IRTC) | 0 | 0 | 0 | $0 | $89.74M | 3.15% | +$89.74M |
| NeoGenomics, Inc.NOTE 0 250 1 1(NEO) | 0 | 0 | 0 | $98.27M | $87.95M | 3.09% | -$10.32M |
| Align Technology Inc | 375,179 | 530,530 | +155,351 | $78.23M | $84.28M | 2.96% | +$6.05M |
| Ironwood Pharmaceuticals, Inc.NOTE 1 500 6 1(IRWD) | 0 | 0 | 0 | $85.21M | $82.54M | 2.90% | -$2.67M |
| CG Oncology, Inc.(CGON) | 3,283,317 | 3,283,317 | 0 | $94.17M | $80.41M | 2.83% | -$13.76M |
| Krystal Biotech, Inc.(KRYS) | 200,500 | 400,744 | +200,244 | $31.41M | $72.25M | 2.54% | +$40.84M |
| BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO) | 0 | 0 | 0 | $148.15M | $72.00M | 2.53% | -$76.15M |
| Thermo Fisher Scientific Inc.(TMO) | 89,754 | 127,733 | +37,979 | $46.69M | $63.56M | 2.23% | +$16.87M |
| Danaher Corporation(DHR) | 0 | 309,339 | +309,339 | $0 | $63.41M | 2.23% | +$63.41M |
| Glaukos Corporation(GKOS) | 288,876 | 624,435 | +335,559 | $43.31M | $61.46M | 2.16% | +$18.14M |
| Nuvalent Inc | 241,235 | 840,945 | +599,710 | $18.88M | $59.64M | 2.10% | +$40.76M |
| iRhythm Holdings, Inc.(IRTC) | 705,391 | 556,391 | -149,000 | $63.61M | $58.24M | 2.05% | -$5.36M |
| Apogee Therapeutics Inc | 1,540,362 | 1,540,362 | 0 | $69.78M | $57.55M | 2.02% | -$12.23M |
| TransMedics Group, Inc.(TMDX) | 922,100 | 854,884 | -67,216 | $57.49M | $57.52M | 2.02% | +$23.7K |
| Guardant Health, Inc.(GH) | 2,847,931 | 1,327,327 | -1,520,604 | $87.00M | $56.54M | 1.99% | -$30.46M |
| Edgewise Therapeutics, Inc.(EWTX) | 2,332,196 | 2,458,808 | +126,612 | $62.27M | $54.09M | 1.90% | -$8.18M |
| Inspire Medical Systems, Inc.(INSP) | 293,410 | 302,410 | +9,000 | $54.39M | $48.17M | 1.69% | -$6.22M |
| BridgeBio Pharma, Inc.NOTE 2 250 2 0(BBIO) | 0 | 0 | 0 | $45.98M | $43.81M | 1.54% | -$2.18M |
| Immunocore Holdings plcNOTE 2 500 2 0(IMCR) | 0 | 0 | 0 | $0 | $43.77M | 1.54% | +$43.77M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 3,452,447 | 1,962,909 | -1,489,538 | $68.29M | $43.60M | 1.53% | -$24.69M |
| Intuitive Surgical, Inc.(ISRG) | 75,300 | 88,000 | +12,700 | $39.30M | $43.58M | 1.53% | +$4.28M |
| Alphatec Holdings, Inc.(ATEC) | 4,256,490 | 4,259,429 | +2,939 | $39.07M | $43.19M | 1.52% | +$4.12M |
| Spyre Therapeutics, Inc.(SYRE) | 2,578,404 | 2,578,404 | 0 | $60.03M | $41.60M | 1.46% | -$18.42M |
| Blueprint Medicines Corp | 0 | 439,968 | +439,968 | $0 | $38.94M | 1.37% | +$38.94M |
| Dyne Therapeutics, Inc.(DYN) | 681,182 | 3,621,344 | +2,940,162 | $16.05M | $37.88M | 1.33% | +$21.83M |
| Apellis Pharmaceuticals Inc COM | 2,098,866 | 1,652,334 | -446,532 | $66.97M | $36.14M | 1.27% | -$30.84M |
| Adaptive Biotechnologies Corporation(ADPT) | 0 | 4,803,794 | +4,803,794 | $0 | $35.69M | 1.25% | +$35.69M |
| Viking Therapeutics, Inc.(VKTX) | 1,479,666 | 1,435,955 | -43,711 | $59.54M | $34.68M | 1.22% | -$24.86M |
| Penumbra, Inc.(PEN) | 183,828 | 110,128 | -73,700 | $43.66M | $29.45M | 1.04% | -$14.21M |
| Bicara Therapeutics Inc | 2,000,659 | 2,162,803 | +162,144 | $34.85M | $28.18M | 0.99% | -$6.67M |
| Day One Biopharmaceuticals I COM | 4,873,853 | 3,536,853 | -1,337,000 | $61.75M | $28.05M | 0.99% | -$33.70M |
| OrthoPediatrics Corp.(KIDS) | 1,107,770 | 1,107,770 | 0 | $25.68M | $27.28M | 0.96% | +$1.61M |
| Harrow, Inc.(HROW) | 907,039 | 956,839 | +49,800 | $30.43M | $25.45M | 0.89% | -$4.98M |
| DexCom, Inc.NOTE 0 375 5 1(DXCM) | 0 | 0 | 0 | $74.38M | $22.80M | 0.80% | -$51.58M |
| Maravai LifeSciences Holdings, Inc.CL A(MRVI) | 8,353,287 | 8,353,287 | 0 | $45.53M | $18.46M | 0.65% | -$27.06M |
| DexCom, Inc.NOTE 0 250 11 1(DXCM) | 0 | 0 | 0 | $17.87M | $18.04M | 0.63% | +$167.3K |
| Xencor, Inc.(XNCR) | 615,531 | 1,655,690 | +1,040,159 | $14.14M | $17.62M | 0.62% | +$3.47M |
| Ascendis Pharma A/SADR(ASND) | 0 | 106,713 | +106,713 | $0 | $16.63M | 0.58% | +$16.63M |
| Oruka Therapeutics, Inc.(ORKA) | 1,147,676 | 1,572,426 | +424,750 | $27.10M | $16.13M | 0.57% | -$10.96M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 48,690 | +48,690 | $0 | $16.13M | 0.57% | +$16.13M |
| Sarepta Therapeutics, Inc.(SRPT) | 364,900 | 234,500 | -130,400 | $44.37M | $14.97M | 0.53% | -$29.40M |
| Replimune Group, Inc.(REPL) | 1,477,102 | 1,461,826 | -15,276 | $17.89M | $14.25M | 0.50% | -$3.63M |
| Repligen Corporation(RGEN) | 283,823 | 81,656 | -202,167 | $40.85M | $10.39M | 0.37% | -$30.46M |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 5,440,277 | 6,622,584 | +1,182,307 | $24.10M | $9.74M | 0.34% | -$14.37M |
| Celcuity Inc.(CELC) | 884,306 | 884,306 | 0 | $11.58M | $8.94M | 0.31% | -$2.64M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,176,173 | 980,773 | -195,400 | $14.33M | $7.42M | 0.26% | -$6.90M |
| Castle Biosciences, Inc.(CSTL) | 0 | 365,247 | +365,247 | $0 | $7.31M | 0.26% | +$7.31M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,206,589 | 375,355 | -831,234 | $26.30M | $6.81M | 0.24% | -$19.49M |
| Alphatec Holdings, Inc.NOTE 0 750 8 0(ATEC) | 0 | 0 | 0 | $55.09M | $5.79M | 0.20% | -$49.30M |
| Pulmonx Corporation(LUNG) | 752,541 | 752,541 | 0 | $5.11M | $5.06M | 0.18% | -$45.2K |
| Metsera Inc | 0 | 175,000 | +175,000 | $0 | $4.76M | 0.17% | +$4.76M |
| Aardvark Therapeutics Inc | 0 | 500,000 | +500,000 | $0 | $3.75M | 0.13% | +$3.75M |
| Aerovate Therapeutics Inc | 1,440,499 | 1,440,499 | 0 | $3.82M | $3.62M | 0.13% | -$201.7K |
| Zura Bio LimitedCL A(ZURA) | 2,472,806 | 2,472,806 | 0 | $6.18M | $3.19M | 0.11% | -$2.99M |
| Beta Bionics, Inc.(BBNX) | 0 | 140,000 | +140,000 | $0 | $1.71M | 0.06% | +$1.71M |
| Skye Bioscience, Inc.(SKYE) | 825,732 | 825,732 | 0 | $2.34M | $1.31M | 0.05% | -$1.02M |
| Trevi Therapeutics, Inc.(TRVI) | 0 | 72,083 | +72,083 | $0 | $453.4K | 0.02% | +$453.4K |
| 4d Molecular Therapeutics In | 1,225,448 | 0 | -1,225,448 | $6.83M | $0 | — | -$6.83M |
| Amphastar Pharmaceuticals, Inc.NOTE 2 000 3 1(AMPH) | 0 | 0 | 0 | $16.28M | $0 | — | -$16.28M |
| Arcus Biosciences, Inc.(RCUS) | 802,100 | 0 | -802,100 | $11.94M | $0 | — | -$11.94M |
| Avadel Pharmaceuticals Plc | 4,105,726 | 0 | -4,105,726 | $43.15M | $0 | — | -$43.15M |
| BioNTech SEADS(BNTX) | 309,865 | 0 | -309,865 | $35.31M | $0 | — | -$35.31M |
| Bruker Corporation(BRKR) | 353,200 | 0 | -353,200 | $20.70M | $0 | — | -$20.70M |
| Candel Therapeutics, Inc.(CADL) | 1,600,000 | 0 | -1,600,000 | $13.89M | $0 | — | -$13.89M |
| CeriBell, Inc.(CBLL) | 210,000 | 0 | -210,000 | $5.43M | $0 | — | -$5.43M |
| Cutera IncNOTE 4 000 6 0 | 0 | 0 | 0 | $2.61M | $0 | — | -$2.61M |
| Cutera IncNOTE 2 250 6 0 | 0 | 0 | 0 | $2.27M | $0 | — | -$2.27M |
| Endeavour Silver Corp.(EXK) | 353,000 | 0 | -353,000 | $19.84M | $0 | — | -$19.84M |
| Geron Corporation(GERN) | 7,006,315 | 0 | -7,006,315 | $24.80M | $0 | — | -$24.80M |
| Guardant Health, Inc.NOTE11 1(GH) | 0 | 0 | 0 | $226.00M | $0 | — | -$226.00M |
| Immatics N.V.SHS(IMTX) | 3,503,965 | 0 | -3,503,965 | $24.91M | $0 | — | -$24.91M |
| Jasper Therapeutics, Inc.(JSPR) | 714,658 | 0 | -714,658 | $15.28M | $0 | — | -$15.28M |
| Keros Therapeutics, Inc.(KROS) | 1,894,439 | 0 | -1,894,439 | $29.99M | $0 | — | -$29.99M |
| Nevro Corp | 1,698,768 | 0 | -1,698,768 | $6.32M | $0 | — | -$6.32M |
| Globus Medical, Inc.NOTE 0 375 3 1(GMED) | 0 | 0 | 0 | $113.21M | $0 | — | -$113.21M |
| Paragon 28 Inc | 3,834,809 | 0 | -3,834,809 | $39.61M | $0 | — | -$39.61M |
| Protagonist Therapeutics Inc | 20,109 | 0 | -20,109 | $776.2K | $0 | — | -$776.2K |
| Vaxcyte, Inc.(PCVX) | 222,424 | 0 | -222,424 | $18.21M | $0 | — | -$18.21M |
| Viridian Therapeutics, Inc.(VRDN) | 34,094 | 0 | -34,094 | $653.6K | $0 | — | -$653.6K |